Short Summary
M/s. Shilpa Medicare Limited filed a commercial appeal against an order, seeking condonation of delay due to initial incorrect nomenclature. The court allowed the delay condonation, noting that procedural rules are handmaids of justice. Subsequently, the court set aside a single judge's order and remanded the matter for consideration on merits, emphasizing continuous infringement.
Detailed Summary
of the Paris Local Division of the Unified Patent Court concerning a request for extension of time filed by the Bosch defendants. The judge-rapporteur rejected Bosch's request, finding that a non-redacted version of Valeo's 15 June 2026 filing had been deposited in the CMS simultaneously with the redacted version, and that Bosch had failed to exercise due diligence in accessing it. The court ruled that the deadlines under R.29(d) RdP run from 15 June 2026.
Practitioner Note
This case demonstrates the evidentiary and procedural standards applied in patent matters before Himachal Pradesh High Court. Understanding the court's reasoning in M/s. Shilpa Medicare Limited vs M/s. Salus Pharmaceutical & anr. is valuable context for structuring arguments or assessing risk in similar proceedings.
Related Cases
Farbenfebriken Bayer AktiengesellschaftvsJoint Controller Of Patents And Designs
The patentee, Farbenfebriken Bayer Aktiengesellschaft, appealed against the Controller's decision to grant compulsory licenses for two patents (Nos. 43678 and 43679) to Arlabs Private Limited. The petitioner sought a certificate under Article 133(1)(c) of the Constitution to appeal further to the Supreme Court.
Emd Millipore CorporationvsAssistant Controller Of Patents And Designs
Emd Millipore Corporation appealed a decision by the Assistant Controller of Patents and Designs which refused its patent application for 'Infrared (IR) Based Quantitation of Biomolecules.' The refusal was based on the grounds that the claimed method constituted an unpatentable diagnostic process under Section 3(i) of the Patents Act, 1970. The Delhi High Court ultimately allowed the appeal, holding that the subject matter did not fall within the scope of this exclusion and that the amendments made were permissible refinements.
B.M.Dhananjaya.SvsM/s.Billionsmiles Hospitality Pvt. Ltd.
The Madras High Court dismissed Original Petition (Trademarks) No. 26 of 2023 after the petitioner, B.M.Dhananjaya.S, filed a request to withdraw the case. The original petition sought the expungement and removal of an entry related to the registered trademark 1485593 from the Trademark Registry. The withdrawal was based on a settlement reached between the contesting parties, concluding the dispute without a formal judicial ruling on the merits.
Cipla LimitedvsUnion Of India Through Department Of Promotion Of Industry And Internal Trade & Anr
The Delhi High Court ruled in favor of Cipla Limited, directing the Trademark Registry to allow the renewal of its 'TRIEXER' trademark. The core finding was that the Registry failed to serve the mandatory statutory 'O3 notice' required under the Trade Marks Act, 1999. Despite the trademark having lapsed and the petitioner failing to file timely renewals, the court emphasized this procedural lapse by the Respondent, granting Cipla a chance to regularize its mark.
Boehringer Ingelheim International GmbHvsFemilab Healthcare
The applicant sought an interim injunction against the respondents for infringing Patent No. 268846 related to Empagliflozin and its formulations. The court, however, noted that the subject patent had already expired, leading to the vacation of the existing interim protection.
Dealing with a patent challenge?
Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.
Disclaimer: This page contains an automated summary based on publicly available judicial records. The content is generated for informational purposes only and does not constitute legal advice. Always verify details against the original source judgment before relying on this information for any legal purpose. If you believe any information is inaccurate, please contact us.